Arnold C. Hanish, Director at Salarius Pharmaceuticals, Inc. (SLRX), bought 5,000 shares at $0.75 ($4K) on 2025-11-20, disclosed to the SEC on 2025-11-24.
Open-market purchase of $4k SLRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| OMER | SELL | 2023-05-23 | $32K | — | Filing → |
| SLRX | BUY | 2022-06-06 | $5K | — | Filing → |
| SLRX | BUY | 2021-08-11 | $6K | — | Filing → |